| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Iain McInnes | Q41687181 |
| Douglas J Veale | Q55686130 | ||
| P2093 | author name string | M D Smith | |
| P P Tak | |||
| D Baeten | |||
| B Bresnihan | |||
| O Fitzgerald | |||
| A-K Ulfgren | |||
| OMERACT synovial special interests group | |||
| P2860 | cites work | Quantitative biomarker analysis of synovial gene expression by real-time PCR | Q24795033 |
| Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy | Q24804272 | ||
| Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis | Q24816628 | ||
| Measurement of cytokine and adhesion molecule expression in synovial tissue by digital image analysis | Q28348514 | ||
| Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA | Q28364842 | ||
| An investigation of the action of disease modifying antirheumatic drugs on the rheumatoid synovial membrane: reduction in T lymphocyte subpopulations and HLA-DP and DQ antigen expression after gold or penicillamine therapy | Q33557146 | ||
| Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane | Q33566324 | ||
| Immunologic intervention in the pathogenesis of osteoarthritis | Q35083974 | ||
| Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity | Q35549067 | ||
| Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis. | Q35550664 | ||
| Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis | Q35553008 | ||
| Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis | Q35553556 | ||
| Technical validation of cDNA based microarray as screening technique to identify candidate genes in synovial tissue biopsy specimens from patients with spondyloarthropathy | Q35554110 | ||
| Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis | Q35554321 | ||
| A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. | Q35554739 | ||
| Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials | Q37154097 | ||
| Quantification of the cell infiltrate in synovial tissue by digital image analysis | Q39528308 | ||
| Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression | Q39579746 | ||
| Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: Implications for pathogenesis and evaluation of treatment | Q39614400 | ||
| Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis | Q39671641 | ||
| Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis | Q39701973 | ||
| Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis | Q39702734 | ||
| Microscopic measurement of cellular infiltration in the rheumatoid arthritis synovial membrane: a comparison of semiquantitative and quantitative analysis | Q40838835 | ||
| Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained blindly by needle biopsy | Q40862663 | ||
| Quantitative analysis of synovial membrane inflammation: a comparison between automated and conventional microscopic measurements | Q41853743 | ||
| Analysis of synovial biopsy samples: opportunities and challenges | Q42149019 | ||
| Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study | Q42643514 | ||
| Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis | Q42685943 | ||
| Analysis of the histologic variation of synovitis in rheumatoid arthritis | Q44072100 | ||
| Changes in lymphocyte infiltration of the synovial membrane and the clinical course of rheumatoid arthritis | Q44388383 | ||
| Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction | Q44960764 | ||
| Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate | Q45099941 | ||
| Microscopic measurement of synovial membrane inflammation in rheumatoid arthritis: proposals for the evaluation of tissue samples by quantitative analysis. | Q47831362 | ||
| Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis | Q47893596 | ||
| Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy | Q49131487 | ||
| Comparative cytokine gene expression in synovial tissue of early rheumatoid arthritis and seronegative spondyloarthropathies. | Q50960152 | ||
| Intraarticular variability of synovial membrane histology, immunohistology, and cytokine mRNA expression in patients with rheumatoid arthritis. | Q51461409 | ||
| Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor α synthesis | Q57350949 | ||
| Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1 | Q67707878 | ||
| Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis | Q71160284 | ||
| Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis | Q71781127 | ||
| Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis. Reduced E-selectin and intercellular adhesion molecule 1 expression | Q71878454 | ||
| In vivo analysis of disease modifying drug therapy activity in rheumatoid arthritis by sequential immunohistological analysis of synovial membrane interleukin 1 beta | Q72354919 | ||
| Synovial membrane inflammation and cytokine production in patients with early osteoarthritis | Q73076908 | ||
| Analysis of serial synovial biopsies in patients with rheumatoid arthritis: description of a control group without clinical improvement after treatment with interleukin 10 or placebo | Q73101125 | ||
| Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane | Q73292536 | ||
| Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis | Q73374703 | ||
| The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis | Q73395900 | ||
| Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis | Q73497787 | ||
| Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis | Q73592210 | ||
| Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue | Q73774978 | ||
| Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsies | Q73782481 | ||
| Variability in cytokine and cell adhesion molecule staining in arthroscopic synovial biopsies: quantification using color video image analysis | Q73987633 | ||
| Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirt | Q74175879 | ||
| The OMERACT filter for Outcome Measures in Rheumatology | Q74267048 | ||
| Distribution of T cells and signs of T-cell activation in the rheumatoid joint: implications for semiquantitative comparative histology | Q74497427 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 93-100 | |
| P577 | publication date | 2005-06-23 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go? | |
| P478 | volume | 65 |
| Q39308974 | Cellular and molecular perspectives in rheumatoid arthritis |
| Q33873677 | Flow cytometric characterization of freshly isolated and culture expanded human synovial cell populations in patients with chronic arthritis |
| Q38844323 | Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis |
| Q33329287 | Image standards in tissue-based diagnosis (diagnostic surgical pathology) |
| Q36401905 | Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure. |
| Q35994130 | Is there a role of synovial biopsy in drug development? |
| Q42119499 | Key Challenges in Rheumatic and Musculoskeletal Disease Translational Research |
| Q59794790 | Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups |
| Q39431367 | Synovial tissue research: a state-of-the-art review |
| Q40576433 | Synovial tissue response to treatment in psoriatic arthritis |
| Q26824354 | Ultrasound-guided synovial biopsy: a systematic review according to the OMERACT filter and recommendations for minimal reporting standards in clinical studies |
| Q34047769 | Utility of arthroscopic guided synovial biopsy in understanding synovial tissue pathology in health and disease states |
| Q90479558 | mTOR Blockade by Rapamycin in Spondyloarthritis: Impact on Inflammation and New Bone Formation in vitro and in vivo |
Search more.